IP to validated diagnostics
Directed R&D translating licensed intellectual property into clinically validated TBI diagnostic assays.
← COPATHOS Leadership
TV
Timothy E. Van Meter, PhD
Director
Diagnostic Technology & Consortium Operations
BRAINBox Solutions, Inc. · Biotesora Public Benefit Corporation
- 20+
- years in assay development
- PhD
- Neuropathology, King's College London
Appointments & Leadership
- Chief Scientific Officer, BRAINBox Solutions, Inc.
- Director of Operations, Biotesora (Public Benefit Corporation supporting COPATHOS Project infrastructure and administration)
- PhD in Neuropathology, King's College London
Professional Impact Summary
Timothy E. Van Meter, PhD, holds a PhD in Neuropathology from King's College London and serves as Chief Scientific Officer of BRAINBox Solutions, Inc., alongside his role as Director of Operations at Biotesora, a public benefit corporation supporting COPATHOS Project infrastructure and administration.
With more than 20 years in assay development, clinical research, and genomics, he has spearheaded international research consortia across multiple domains and directed R&D translating licensed intellectual property into clinically validated TBI diagnostic assays.
Experience & consortia leadership
- 20+ years in assay development, clinical research, and genomics.
- Spearheaded international research consortia across multiple domains.
Key scientific contributions
Discovery to regulatory-ready products
Bridging discovery science to regulatory-ready diagnostic products for clinical deployment.
Areas of expertise
- Epigenetics
- Translational Models
- Diagnostic Bioassay Development
- Regulatory Pathway Strategy
- Genomics
- Clinical Research
- AI-enabled precision medicine
- Digital Health
- Medical device integration